EICHOR
● Completed
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
Condition: Stable Coronary Artery Disease · Sponsor: Viatris Innovation GmbH
About this study
The goal of this study is to find out if a drug called selatogrel (ACT-246475) can prevent platelets from binding together when administered by an injection under the skin in the thigh or in the belly. Another goal is to know how fast and for how long selatogrel (ACT-246475) works and if there is a difference if the drug is injected in the thigh or in the belly. This study will also help to find out more about the safety of this new drug.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (20)
| University of Florida (UF) Jacksonville | Jacksonville, Florida, United States | — |
| Florida Hospital Tampa - Pepin Heart Institute | Tampa, Florida, United States | — |
| NorthShore University | Chicago, Illinois, United States | — |
| Indiana University School of Medicine - Krannert Institute of Cardiology | Indianapolis, Indiana, United States | — |
| Inova Cardiology | Lutherville, Maryland, United States | — |
| Mount Sinai Hospital (New York) | New York, New York, United States | — |
| Inova Center for Thrombosis Research and Translational Medicine | Falls Church, Virginia, United States | — |
| Institut de Cardiologie de Montréal | Montreal, Quebec, Canada | — |
| Aarhus University Hospital | Aarhus, Denmark | — |
| Rigshospitalet | Copenhagen, Denmark | — |
| Universitats-Herzzentrum | Bad Krozingen, Germany | — |
| University Medical Center Groningen | Groningen, Netherlands | — |
+ 8 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.